Programming by Estrogen Treatment in Gonadotropin Releasing Hormone Antagonist Protocol
- Registration Number
- NCT01419353
- Lead Sponsor
- Meir Medical Center
- Brief Summary
The purpose of this study is to determine if pretreatment with Estrogen can assist in the planning and programming of In Vitro Fertilization treatments.
- Detailed Description
A randomised controlled trial in which study group will be given estrogen derivative before ovarian stimulation in GnRH antagonist protocol and compared to the classical GnRH agonist protocol.Estrogen will be given P.O , "PROGYNOVA' , in a dose of 2 mg /d, starting day 2 of menses and until first Monday to follow. Main outcome measure will be ability to control the ovum pickup day, calculated as a rate of ideal pickups divided by the entire pickup number. All women enrolled will be under 38 years of age, with a clear indication for IVF other than ovulatory dysfunction. women with past 4 treatment failures will be excluded as well as cases in which sperm achieved in surgical methods.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 63
- IVF treatment in the following indications: Male, Mechanical, Unexplained
- Age<38 years
- Treatment Cycle number 1-4
- Ovulatory disorder as an indication for IVF
- Repeated failure in previous IVF treatments (> than 4 cycles)
- Sperm used for treatment was retrieved by surgical procedure
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Follicular Estrogen, Antagonist, IVF estradiol valerate Follicular Estrogen in Antagonist IVF protocol long IVF protocol estradiol valerate long IVF protocol
- Primary Outcome Measures
Name Time Method ovum pickup rate that took place between Sunday to Thursday without a compromise a year number of Pickups that took place between Sunday to Thursday (without a compromise in treatment) \\ by the entire pickup number
- Secondary Outcome Measures
Name Time Method pregnancy rate a year comparison of pregnancy rate between the 2 groups. calculated per cycle
Trial Locations
- Locations (1)
Meir Medical Center
🇮🇱Kfar Saba, Israel